Printer Friendly

Cell-based assays market.

LONDON, U.K., November 12, 2015 - The global cell-based assays market is expected to reach $18 million by 2020 from $11 million in 2015, growing at a CAGR of 11 percent between 2015 and 2020, according to a report.

The product segments included in this report are consumables, instruments, services and software.

The consumables segment is further segmented into reagents and assay kits, cell lines, and micro plates. Reagents and assay kits include reporter gene assays, second messenger assays, cell growth assays, cell death assays and other assays.

Cell lines include immortalized cell lines, primary cell lines and stem cell lines.

Applications include basic research, drug discovery, predictive toxicology, ADME studies and other applications.

Drug discovery had the largest share of the market in 2015. Predictive toxicology is expected to be one of the fastest growing applications between 2015 and 2020.

The report covers North America, Europe, Asia and the rest of the world (RoW). North America accounted for the largest share in the market in 2015. Asia is expected to register a faster growth from 2015 to 2020.

The key driver for this market is increased R&D spending on research. Furthermore, growing benefits of cell-based assays over other methods, their increasing adoption in drug discovery, and advancements in automation and high-throughput techniques will aid market growth.

"Cell-based Assays Market by Product, Applications, End User, & Region - Global Forecast to

2020," November 2015, MarketsandMarkets, 178 pages, $4,650.

Contact: https://goo.gl/l90zh7

COPYRIGHT 2015 DataTrends Publications, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2015 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Market Research
Publication:Stem Cell Business News
Date:Nov 16, 2015
Words:243
Previous Article:Mesoblast lists on NASDAQ.
Next Article:Should NIH lift funding restrictions on chimeric research?

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters